Stocks · Health care · Pharmaceutical Preparations

Werewolf Therapeutics, Inc.

HOWL Clue Score19
United States Fiscal year ends December CIK 0001785530 Results filed 31 Jul 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ansbert Gadicke
27 Mar 2025
10% owner
Sold after exercise indirect
4,386
$1.05
$4.61K
Luke Evnin
27 Mar 2025
Director
Sold after exercise indirect
2,425
$1.05
$2.55K
MPM BioVentures 2014, L.P.
27 Mar 2025
10% owner
Sold after exercise indirect
1,963
$1.05
$2.06K

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 37
Sales on a Rule 10b5-1 plan 143
Sales straight out of an exercise 3
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 27,131,842
Sales filed before the plan box existed 2
History held since 3 May 2021